SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-014319
Filing Date
2010-03-18
Accepted
2010-03-18 13:21:57
Documents
3
Period of Report
2009-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v177867_8k.htm 8-K 26687
2 v177867_ex10-1.htm EX-10.1 82267
3 GRAPHIC map1.jpg GRAPHIC 24868
  Complete submission text file 0001144204-10-014319.txt   145519
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI, SHANDONG F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI, SHANDONG F4 710075 5619889880
Jiangbo Pharmaceuticals, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-53037 | Film No.: 10690985
SIC: 2834 Pharmaceutical Preparations